Cargando…
Pharmacogenomic technologies: a necessary "luxury" for better global public health?
BACKGROUND: Pharmacogenomic technologies aim to redirect drug development to increase safety and efficacy of individual care. There is much hope that their implementation in the drug development process will help respond to population health needs, particularly in developing countries. However, ther...
Autores principales: | Olivier, Catherine, Williams-Jones, Bryn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175439/ https://www.ncbi.nlm.nih.gov/pubmed/21864366 http://dx.doi.org/10.1186/1744-8603-7-30 |
Ejemplares similares
-
Why is repositioning public health innovation towards a social paradigm necessary? A reflection on the field of public health through the examples of Ebola and Covid-19
por: Niang, Marietou, et al.
Publicado: (2021) -
Pain as a global public health priority
por: Goldberg, Daniel S, et al.
Publicado: (2011) -
Migration and health: a global public health research priority
por: Wickramage, Kolitha, et al.
Publicado: (2018) -
Global public goods and the global health agenda: problems, priorities and potential
por: Smith, Richard D, et al.
Publicado: (2007) -
Why meta-regulation matters for public health: the case of the EU better regulation agenda
por: Lauber, Kathrin, et al.
Publicado: (2023)